Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN)
ChromaDex Corp. (NASDAQ:CDXC) announced that Dr. Yasmeen Nkrumah-Elie, their Global Director of External Research, has been honored with the inaugural Trailblazing Woman Award by Radicle Science and the Council for Responsible Nutrition (CRN). This award recognizes Dr. Nkrumah-Elie's contributions to the dietary supplement and functional food industry through leadership, innovation, and mentorship.
Dr. Nkrumah-Elie has led ChromaDex's External Research Program (CERP) to become an industry-leading initiative with nearly 300 research collaborations worldwide, over 30 published clinical trials, and several intellectual property opportunities. She is also active in various industry organizations, advocating for diversity, equity, and inclusion.
The award highlights Dr. Nkrumah-Elie's commitment to advancing scientific excellence, promoting diversity, and mentoring the next generation of female leaders in the industry.
ChromaDex Corp. (NASDAQ:CDXC) ha annunciato che la Dott.ssa Yasmeen Nkrumah-Elie, loro Direttore Globale della Ricerca Esterna, è stata onorata con il primo Trailblazing Woman Award da Radicle Science e dal Council for Responsible Nutrition (CRN). Questo premio riconosce i contributi della Dott.ssa Nkrumah-Elie all'industria degli integratori alimentari e dei cibi funzionali attraverso la leadership, l'innovazione e il mentoring.
La Dott.ssa Nkrumah-Elie ha guidato il Programma di Ricerca Esterna di ChromaDex (CERP), che è diventato un'iniziativa leader nel settore con quasi 300 collaborazioni di ricerca in tutto il mondo, oltre 30 studi clinici pubblicati e diverse opportunità di proprietà intellettuale. È anche attiva in diverse organizzazioni del settore, sostenendo la diversità, l'equità e l'inclusione.
Il premio evidenzia l'impegno della Dott.ssa Nkrumah-Elie nel promuovere l'eccellenza scientifica, la diversità e il mentoring della prossima generazione di leader femminili nel settore.
ChromaDex Corp. (NASDAQ:CDXC) anunció que la Dra. Yasmeen Nkrumah-Elie, su Directora Global de Investigación Externa, ha sido honrada con el primer Trailblazing Woman Award por Radicle Science y el Council for Responsible Nutrition (CRN). Este premio reconoce las contribuciones de la Dra. Nkrumah-Elie a la industria de los suplementos dietéticos y alimentos funcionales a través de su liderazgo, innovación y mentoría.
La Dra. Nkrumah-Elie ha dirigido el Programa de Investigación Externa de ChromaDex (CERP) para convertirse en una iniciativa líder en la industria, con casi 300 colaboraciones de investigación en todo el mundo, más de 30 ensayos clínicos publicados y varias oportunidades de propiedad intelectual. También está activa en diversas organizaciones de la industria, abogando por la diversidad, la equidad y la inclusión.
El premio destaca el compromiso de la Dra. Nkrumah-Elie con la excelencia científica, la promoción de la diversidad y la mentoría de la próxima generación de líderes femeninas en la industria.
ChromaDex Corp. (NASDAQ:CDXC)는 그들의 글로벌 외부 연구 담당 이사인 Dr. Yasmeen Nkrumah-Elie가 Radicle Science와 책임 있는 영양을 위한 협의회(CRN)에서 제정한 첫 번째 Trailblazing Woman Award를 수상했다고 발표했습니다. 이 상은 Nkrumah-Elie 박사의 다이어트 보충제 및 기능성 식품 산업에 대한 기여를 리더십, 혁신, 멘토링을 통해 인정하는 것입니다.
Nkrumah-Elie 박사는 ChromaDex의 외부 연구 프로그램(CERP)을 이끌어 거의 300개의 연구 협력과 30편 이상의 임상 시험, 여러 지적 재산 기회를 가진 업계 선도적 이니셔티브로 성장시켰습니다. 그녀는 다양한 산업 조직에도 활동적으로 참여하며 다양성, 형평성 및 포함을 옹호하고 있습니다.
이 상은 Nkrumah-Elie 박사가 과학적 우수성을 발전시키고, 다양성을 촉진하며, 산업 내 차세대 여성 지도자들을 멘토링하는 데 헌신하고 있음을 강조합니다.
ChromaDex Corp. (NASDAQ:CDXC) a annoncé que Dr. Yasmeen Nkrumah-Elie, leur directrice mondiale de la recherche externe, a été honorée par le premier prix Trailblazing Woman décerné par Radicle Science et le Council for Responsible Nutrition (CRN). Ce prix reconnaît les contributions de Dr. Nkrumah-Elie à l'industrie des compléments alimentaires et des aliments fonctionnels à travers son leadership, son innovation et son mentorat.
Dr. Nkrumah-Elie a dirigé le programme de recherche externe de ChromaDex (CERP), qui est devenu une initiative leader dans l'industrie avec près de 300 collaborations de recherche à travers le monde, plus de 30 essais cliniques publiés et plusieurs opportunités de propriété intellectuelle. Elle est également active dans diverses organisations de l'industrie, plaidant pour la diversité, l'équité et l'inclusion.
Le prix met en lumière l'engagement de Dr. Nkrumah-Elie à faire progresser l'excellence scientifique, à promouvoir la diversité et à encadrer la prochaine génération de femmes leaders dans l'industrie.
ChromaDex Corp. (NASDAQ:CDXC) hat bekannt gegeben, dass Dr. Yasmeen Nkrumah-Elie, ihre Global Director of External Research, mit dem inaugural Trailblazing Woman Award von Radicle Science und dem Council for Responsible Nutrition (CRN) ausgezeichnet wurde. Diese Auszeichnung würdigt Dr. Nkrumah-Elies Beiträge zur Diät- und Lebensmittelfunktionalitäten-Industrie durch Leadership, Innovation und Mentoring.
Dr. Nkrumah-Elie hat das externe Forschungsprogramm von ChromaDex (CERP) geleitet und es zu einer führenden Initiative in der Branche mit nahezu 300 Forschungskooperationen weltweit, über 30 veröffentlichten klinischen Studien und mehreren Möglichkeiten im Bereich geistiges Eigentum entwickelt. Zudem ist sie in verschiedenen Branchenorganisationen aktiv und setzt sich für Diversität, Chancengleichheit und Inklusion ein.
Der Preis hebt das Engagement von Dr. Nkrumah-Elie hervor, wissenschaftliche Exzellenz voranzutreiben, Diversität zu fördern und die nächste Generation weiblicher Führungskräfte in der Branche zu unterstützen.
- Recognition of ChromaDex's Global Director of External Research with a prestigious industry award
- ChromaDex External Research Program (CERP) has nearly 300 research collaborations worldwide
- CERP has produced over 30 published clinical trials
- CERP has generated several intellectual property opportunities
- None.
This award recognizes Dr. Nkrumah-Elie’s dedication to advancing scientific excellence for ChromaDex’s leading external research program and mentorship in the dietary supplement industry
Yasmeen Nkrumah-Elie, Ph.D accepts the Trailblazing Woman Award on stage during CRN’s CONVERGENCE Conference (Photo: Business Wire)
“I am deeply honored to receive the Trailblazing Woman Award,” said Dr. Nkrumah-Elie, “and I am moved by the collective force of inspiring women leading within our dietary supplement industry who continue to push the boundaries of what’s possible—as my fellow finalists demonstrate. I am grateful for the opportunity to be a part of an industry dedicated to advancing wellness and improving global health.”
The Trailblazing Woman Award honors women who have made remarkable contributions to the dietary supplement and functional food industry through leadership, innovation, and mentorship. Dr. Nkrumah-Elie was selected for her extraordinary commitment to advancing science, promoting diversity, and mentoring the next generation of female leaders.
In addition to her leadership role at ChromaDex, Dr. Nkrumah-Elie is a member of CRN’s Senior Scientific Advisory Council and actively contributes to several industry organizations, including Women In Nutraceuticals (WIN) and the American Society for Nutrition, where she advocates for diversity, equity, and inclusion. She is a frequent speaker at industry conferences, where she shares her knowledge and helps bridge the gap between science and broader audiences.
Andrew Shao, PhD., Senior Vice President, Global Scientific and Regulatory Affairs, ChromaDex, commented: “Dr. Nkrumah-Elie has led the evolution of the ChromaDex External Research Program (CERP) to become an award-winning and industry-leading research program. Under her leadership, CERP has amassed nearly 300 research collaborations with institutions around the world, over 30 published clinical trials and several intellectual property opportunities. Dr. Nkrumah-Elie and her dedicated team have elevated CERP to become the gold standard for industry-academia collaboration.”
“We’re thrilled to celebrate Dr. Nkrumah-Elie’s remarkable achievements and the lasting impact she’s made on our industry,” said Pelin Thorogood, Co-Founder and Executive Chairwoman of Radicle Science. “A brilliant researcher, Dr. Nkrumah-Elie’s influence extends far beyond her scientific contributions—she’s a mentor, a connector, and a fierce advocate for women in science. Her passion for creating opportunities and uniting people in meaningful ways is why she’s such a worthy recipient of our inaugural Trailblazing Woman Award.”
“We appreciate Dr. Nkrumah-Elie’s engagement and leadership in the CRN member community,” said Andrea Wong, Ph.D., CRN Senior Vice President, Scientific and Regulatory Affairs. “Her depth of knowledge, combined with her dedication to advancing scientific excellence and mentoring future generations, has made a significant impact.”
About ChromaDex:
ChromaDex Corp. (NASDAQ:CDXC) is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. The ChromaDex team, composed of world-renowned scientists, works with independent investigators from esteemed universities and research institutions around the globe to uncover the full potential of NAD+. A vital coenzyme found in every cell of the human body, NAD+ declines with age and exposure to other everyday stressors. NAD+ depletion is a contributor to age-related changes in health and vitality.
Setting the benchmark as the gold standard in scientific rigor, safety, quality, and transparency, ChromaDex is the innovator behind its clinically proven flagship ingredient, Niagen (patented nicotinamide riboside, or NR), the most efficient and superior-quality NAD+ booster available.
Niagen® is the active ingredient in ChromaDex’s consumer products, sold as the brand Tru Niagen®, the number one healthy-aging NAD+ supplement in
ChromaDex’s robust patent portfolio protects NR and other NAD+ precursors. ChromaDex maintains a website at www.chromadex.com, where copies of press releases, news, and financial information are regularly published.
†Based on the top-selling dietary supplement brands by revenue per the largest
View source version on businesswire.com: https://www.businesswire.com/news/home/20241015810330/en/
ChromaDex Media Contact:
Kendall Knysch, Senior Director of Media Relations & Partnerships
310-388-6706 ext. 689
kendall.knysch@chromadex.com
ChromaDex Investor Relations Contact:
Ben Shamsian
Lytham Partners
646-829-9701
shamsian@lythampartners.com
Source: ChromaDex Corporation
FAQ
What award did ChromaDex's Dr. Yasmeen Nkrumah-Elie receive?
How many research collaborations does ChromaDex's External Research Program (CERP) have?
How many clinical trials has ChromaDex's CERP published?
What is ChromaDex's stock symbol?
